Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma ”), a biopharmaceutical company focused on developing ...
Ocrelizumab is associated with increased risks for infection and hospitalization among older adults with multiple sclerosis, ...
Late-breaking data from positive Phase III REMODEL-1/-2 trials will show efficacy and safety profile of remibrutinib in RMS ...
Multiple sclerosis study reveals strengths in primary care knowledge but gaps in diagnosis and relapse treatment.
A new meta-analysis of thirteen randomized controlled trials finds that vestibular rehabilitation improves balance, gait, ...
If ongoing studies demonstrate favorable safety and efficacy profiles, CAR T-cell therapy may establish a novel treatment ...
A new single-cell and animal study links SLC7A11-high astrocyte states to antioxidant failure and synaptic remodeling in ...
Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company advancing ...
Lancashire Evening Post on MSN
Mum with multiple sclerosis loses driving licence after blunder labelled her mentally unstable
Jennifer Ashworth, a 54-year-old mother with multiple sclerosis, has been left unable to leave her home after her driving ...
The National MS Society launched a 'Campaign to End MS,' aiming to raise $1 billion for research and to improve access to ...
Neurologists Robert Bermel, MD; Rebecca Cebull, CNP; and Marisa McGinley, DO, discuss where serum neurofilament light and GFAP fit into MS care today and why the field is still waiting on a biomarker ...
Amazon S3 on MSN
Daughter surprises mom with multiple sclerosis by wearing her old wedding dress | Happily
A loving daughter surprised her mom, who suffers from multiple sclerosis, by wearing her old wedding dress. Jo Johnson Overby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results